About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

UNKNOWNNA

Early Therapy Response Monitoring in Melanoma Patients Using PET/MRI

Early Response Monitoring of Systemic Therapies in Patients With Advanced Melanoma by Simultaneous Positron-emission-tomography (PET)/Magnetic Resonance Imaging (MRI)

NCT03132090•University Hospital Tuebingen

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Malignant Melanoma Stage IV

Interventions

PET/MR (Biograph mMR)

Locations

1

Germany

Locations (1)

Dept. of Radiology, University of Tuebingen

Tübingen, Germany

Key Dates

Start Date

September 29, 2014

Primary Completion Date

January 1, 2018

Completion Date

June 1, 2018

Last Updated

April 27, 2017

Related Studies

Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients with Metastatic Malignant Melanoma Treated with Targeted Therapies or Immunotherapy ( MALT )

NCT03493230

Malignant Melanoma Stage IVMalignant Melanoma Stage III

COMPLETEDPhase 2

mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma

NCT01676779

Malignant Melanoma Stage IIIMalignant Melanoma Stage IV

COMPLETEDPhase 2

Vemurafenib + Fotemustine to Treat Advanced Melanoma Patients With V600BRAF Mutation Recurred While on Vemurafenib

NCT01983124

Malignant Melanoma Stage IV

TERMINATEDPhase 2

Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients

NCT00722098

Malignant Melanoma Stage IV

Contacts

Nina Schwenzer, MD

CONTACT

+49 7071 29-87720 nina.schwenzer@uni-tuebingen.de

Sponsors

Lead Sponsor

University Hospital Tuebingen

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 27, 2017Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions